ZYUS LIFE SCIENCES CORPORATION |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.02 CAD | -1.92% |
|
-1.92% | +13.33% |
| 05-07 | ZYUS Life Sciences Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 04-23 | ZYUS Life Sciences Receives US Patent for Pain Management Drug Candidate | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 53.78M | - | - | - | - | - | |
| 62.86B | - | |||||
| 41.38B | ||||||
| 40.38B | ||||||
| 27.64B | ||||||
| 26.46B |
